Johnson & Johnson’s Newest Multibillion Dollar Acquisition
After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared on Wednesday.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 46
The FDA Comes Down on Gilead and Galapagos With CRL
The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.
What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia
BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia A.
Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia
Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.
BofA Securities Adds Medical Technology Giant to the US 1 List
With the market showing the potential for some sizable rotation, the research team at BofA Securities has added Medtronic to the firm's US 1 List of top stocks to buy. It and three other…
XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy
XBiotech shares made a handy gain on Monday after the company said that it has identified True Human antibodies that could potentially be used as a therapy against SARS-CoV2.
Unity Bio Stock Is Literally Kneecapped
Unity Biotechnology stock was absolutely crushed on Monday after the company announced results from its midstage study in patients with moderate-to-severe painful osteoarthritis of the knee.
What Sanofi Is Adding to Its Portfolio With This New Acquisition
Principia Biopharma shares jumped to start out the week after it was announced that it would be acquired by Sanofi.
5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential
These are five biotech and medtech stocks for very aggressive accounts that look to get shares count leverage on companies that have sizable upside potential.
CureVac Enters the Market With a Bang
CureVac stock exploded into the market, more than double its original pricing. Since then, it is up more or less triple its original pricing.
Hydroxychloroqine Could Be Back in Play With Recent Taiwan FDA Filing
Taiwan Liposome Co. Ltd (NASDAQ: TLC) shares shot higher on Friday after the company announced it was making a regulatory filing for a COVID-19 treatment that has been at the center of some controversy.
As COVID-19 Spreads Across America, New York Still Has Most Deaths By Far
New York State may rank fourth in COVID-19 confirmed case count, but its death toll is well over twice that of any other state in the country.
Over 500,000 US COVID-19 Deaths Forecast This Year
There are several academic models of how many Americans will die of COVID-19 this year. One puts the number at well over 500,000.
Moderna’s New Deal: Is This a Case of ‘Sell the News’?
When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of “sell the news,” because this is ultimately a net positive for the company.
How Is Royalty Pharma Poised After Earnings?
Royalty Pharma reported quarterly results on Wednesday morning that were boosted by Imbruvica and the addition of new royalties.